Point-of-Care Infectious Disease Diagnostics Market Growth and SWOT Analysis By Top Players Abbott Laboratories, Danaher Corporation, F.Hoffman-La Roche Ltd., Orchard Software Corporation, Siemens Healthcare GmbH, Telecor, Inc., Thermo Fisher Scientific,

Point of care diagnostics are efficient in emerging economies of Asia Pacific wherein infectious diseases and especially tropical disease such as malaria are highly prevalent. Infectious point of care testing serves advantages such as increasing access to care in remote areas, time and cost efficiency, and rapid diagnosis, which can greatly affect treatment outcome. Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016. According to the World Health Organization (WHO), 2016, around 10.4 million people were affected with tuberculosis and an estimated 1 million pediatric population was affected with tuberculosis.

Download PDF Brochure of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-pdf/63

Technological advancements to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. For instance, Becton Dickinson and Company launched point-of-care system BD FACSPresto in 2014 for HIV/AIDS patients. This CD4 counter system provides percentage results of CD4 T lymphocytes and hemoglobin concentration to stage and monitor HIV/AIDS patients. OraSure Technologies, Inc., announced prequalification of its OraQuick HIV Self-Test by the World Health Organization (WHO). This prequalification ensure that diagnostic tests severe diseases meet global standards of quality, safety, and efficacy.

Alere, Inc. launched first-ever rapid diagnostic test, Malaria Ag P.f, for detection of asymptomatic malaria infection in May 2017. Furthermore, Infectious Disease Research Institute (IDRI) developed a fusion antigen in January 2017, which is used as a part of diagnostic test manufactured by InBios International, Inc. for Chagas disease. Trinity Biotech plc received CE marking for Uni-Gold H. pylori Antigen point-of-care test in 2014. The Uni-Gold H. pylori Antigen is a 15 min rapid test, used to aid in the diagnosis of Helicobacter pylori (H. pylori) infection and to monitor the effectiveness of treatment. Furthermore, Cepheid received the U.S. Food & Drug Administration clearance and CLIA waiver for Xpert Xpress Flu test in January 2018. GenePOC announced CE marking of its revogene instrument in January 2017, and successfully combined the CE mark for the revogene instrument with two critical tests, GBS and C.diff. The company intends to build a menu of tests for infectious diseases, including hospital acquired infections.

Market Dynamics

Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer’s supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.

Request For Customization Of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-customization/63

Major players operating in the point of care infectious disease diagnostics market include Danaher Corporation, Abbott Laboratories, Alcon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.

Global Point of Care Infectious Disease Diagnostics Market, By Technology:
Lateral Flow
Agglutination Assays
Flow-Through
Solid Phase
Global Point of Care Infectious Disease Diagnostics Market, By Application:
HIV
Tropical Disease
Liver Disease
Inflammatory Disease
Respiratory Disease
Hospital Associated Infections (HAIs)
Sexual Health Disorders
Others
Global Point of Care Infectious Disease Diagnostics Market, By End User:
Hospitals
Diagnostic Laboratories
Home-Care Settings
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.